SCHEMBL13740973

SCHEMBL13740973

C=CCN(c1ccccn1)c1ccccn1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.52
CYP2C19 P33261 1/20 0.52
HDAC1 Q13547 2/20 0.40
HDAC6 Q9UBN7 2/20 0.40
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC5 Q9UQL6 1/20 0.40
MAPT P10636 2/20 0.38
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
ATM Q13315 1/20 0.37
ALDH1A1 P00352 2/20 0.37
CHRM2 P08172 1/20 0.37
ADRA2A P08913 1/20 0.37
ADRA2B P18089 1/20 0.37
ADRA2C P18825 1/20 0.37
DRD1 P21728 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10619140 0.91 CYP2D6 (0.47) CYP2D6CYP2C19HDAC1HDAC6HDAC3
SCHEMBL28002283 0.88 CYP2D6 (0.42) CYP2D6CYP2C19HDAC1HDAC6HDAC3
SCHEMBL175241 0.84 CHRM2 (0.44) CYP2D6CYP2C19MAPTNPC1RAB9A
SCHEMBL11299481 0.84 CYP2D6 (0.41) CYP2D6CYP2C19HDAC1HDAC6HDAC3
SCHEMBL9278864 0.82 CYP2D6 (0.42) CYP2D6CYP2C19HDAC1HDAC6HDAC3
SCHEMBL4070519 0.81 CYP2D6 (0.49) CYP2D6CYP2C19MAPTKMT2AMEN1
SCHEMBL9302381 0.81 CYP2D6 (0.41) CYP2D6CYP2C19HDAC1HDAC6HDAC3
SCHEMBL31497259 0.81 CYP2D6 (0.49) CYP2D6CYP2C19MAPTKMT2AMEN1
SCHEMBL9300866 0.81 CYP2D6 (0.41) CYP2D6CYP2C19HDAC1HDAC6HDAC3
SCHEMBL6395273 0.81 CYP2D6 (0.41) CYP2D6CYP2C19HDAC1HDAC6HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118223047-A Method for synthesizing N-Mannich alkali compound by taking methanol as carbon source under electric assistance 天津科技大学 2024-06-21 CN disclosed
US-9051345-B2 Metalloinsertor complexes targeted to DNA mismatches CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2015-06-09 US disclosed
US-8859533-B2 Metalloinsertor complexes targeted to DNA mismatches CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2014-10-14 US disclosed
EP-2707377-A2 METALLOINSERTOR COMPLEXES TARGETED TO DNA MISMATCHES California Institute of Technology (US) 2014-03-19 EP disclosed
US-20130345189-A1 METALLOINSERTOR COMPLEXES TARGETED TO DNA MISMATCHES NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2013-12-26 US disclosed
CN-101400640-B Method for producing 1,2-phenylethane compound using atom transfer radical coupling reaction NIPPON SODA CO 2013-05-08 CN disclosed
US-20130090319-A1 METALLOINSERTOR COMPLEXES TARGETED TO DNA MISMATCHES CALIFORNIA INSTITUTE OF TECHNOLOGY 2013-04-11 US disclosed
WO-2012155004-A2 METALLOINSERTOR COMPLEXES TARGETED TO DNA MISMATCHES CALIFORNIA INSITUTE OF TECHNOLOGY (US) 2012-11-15 WO disclosed
CN-101087813-B Method for removing metal and method for producing polymer NIPPON SODA CO 2010-05-12 CN disclosed
CN-100594184-C Dispersion of titanium oxide particles, titanium oxide thin film, solution for forming organic functional film, substrate having organic functional film formed thereon and method for producing same NIPPON SODA CO 2010-03-17 CN disclosed
CN-100551944-C Polymer solid electrolyte NIPPON SODA CO (JP) 2009-10-21 CN disclosed
CN-101115682-A Dispersion of titanium oxide particles, titanium oxide thin film, solution for forming organic functional film, substrate having organic functional film formed thereon and method for producing same NIPPON SODA CO (JP) 2008-01-30 CN disclosed
CN-101087813-A Method for removing metal and method for producing polymer NIPPON SODA CO (JP) 2007-12-12 CN disclosed
CN-1668662-A Solid polymer electrolyte NIPPON SODA CO (JP) 2005-09-14 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130090319-A1 METALLOINSERTOR COMPLEXES TARGETED TO DNA MISMATCHES MSH2, MSH6, PMS2 CYP2D6 2293/4885CYP2C19 3522/4885HDAC1 3701/4885
US-20130345189-A1 METALLOINSERTOR COMPLEXES TARGETED TO DNA MISMATCHES MSH2, MSH6, PMS2 CYP2D6 2293/4885CYP2C19 3522/4885HDAC1 3701/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.